# US 2003/0232803 A1 · Crystalline 1-methylcarbapenem derivatives

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0232803 A1
- Document ID: US20030232803A1
- Status: Published application
- Kind: A1
- Application number: 10/407,546
- Filed: 2003-04-03
- Published: 2003-12-18
- Earliest claimed: 1999-07-06
- Assignees: Sankyo Company, Limited
- Inventors: Isao Kawamoto; Yasuo Shimoji; Hiroshi Fukuhara
- Web page: https://patentgrep.com/patent/US20030232803A1

## CPC

- C07D 477/20: Sulfur atoms
- A61K 31/407: condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P 31/04: Antibacterial agents
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

This invention provides crystalline forms of a 1-methylcarbapenem derivative of formula (I) or of pharmaceutically acceptable salts thereof. 1 The crystalline forms of the 1-methylcarbapenem derivative exhibit excellent antibiotic activity against various bacterial strains and sufficient stability for practical use.

## Claims

### Claim 1

A 1-methylcarbapenem derivative of formula (I) or a pharmaceutically acceptable salt thereof in crystalline form:
16

### Claim 2

A 1-methylcarbapenem derivative of formula (I-1) in crystalline form:
17

### Claim 3

A 1-methylcarbapenem derivative of formula (I-2) in crystalline form:
18

### Claim 4

A 1-methylcarbapenem derivative of formula (I) in crystalline form:
19

### Claim 5

A 1-methylcarbapenem derivative of formula (I-3) in crystalline form:
20

### Claim 6 (depends on 1)

A pharmaceutical composition for the prevention or treatment of bacterial infections comprising a therapeutically effective amount of a 1-methylcarbapenem derivative of formula (I) or a pharmaceutically acceptable salt thereof in crystalline form as claimed in claim 1 as an active ingredient together with a diluent or carrier therefor.

### Claim 7 (depends on 2)

A pharmaceutical composition for the prevention or treatment of bacterial infections comprising a therapeutically effective amount of a 1-methylcarbapenem derivative of formula (I-1) in crystalline form as claimed in claim 2 as an active ingredient together with a diluent or carrier therefor.

### Claim 8 (depends on 3)

A pharmaceutical composition for the prevention or treatment of bacterial infections comprising a therapeutically effective amount of a 1-methylcarbapenem derivative of formula (I-2) in crystalline form as claimed in claim 3 as an active ingredient together with a diluent or carrier therefor.

### Claim 9 (depends on 4)

A pharmaceutical composition for the prevention or treatment of bacterial infections comprising a therapeutically effective amount of a 1-methylcarbapenem derivative of formula (I) in crystalline form as claimed in claim 4 as an active ingredient together with a diluent or carrier therefor.

### Claim 10 (depends on 5)

A pharmaceutical composition for the prevention or treatment of bacterial infections comprising a therapeutically effective amount of a 1-methylcarbapenem derivative of formula (I-3) in crystalline form as claimed in claim 5 as an active ingredient together with a diluent or carrier therefor.

### Claim 11 (depends on 1)

A method for preventing or treating bacterial infections which comprises administering to a warm-blooded animal in need of such prevention or treatment a pharmacologically effective amount of a 1-methylcarbapenem derivative of formula (I) or a pharmaceutically acceptable salt thereof in crystalline form as claimed in claim 1.

### Claim 12 (depends on 2)

A method for preventing or treating bacterial infections which comprises administering to a warm-blooded animal in need of such prevention or treatment a pharmacologically effective amount of a 1-methylcarbapenem derivative of formula (I-1) in crystalline form as claimed in claim 2.

### Claim 13 (depends on 3)

A method for preventing or treating bacterial infections which comprises administering to a warm-blooded animal in need of such prevention or treatment a pharmacologically effective amount of a 1-methylcarbapenem derivative of formula (I-2) in crystalline form as claimed in claim 3.

### Claim 14 (depends on 4)

A method for preventing or treating bacterial infections which comprises administering to a warm-blooded animal in need of such prevention or treatment a pharmacologically effective amount of a 1-methylcarbapenem derivative of formula (I) in crystalline form as claimed in claim 4.

### Claim 15 (depends on 5)

A method for preventing or treating bacterial infections which comprises administering to a warm-blooded animal in need of such prevention or treatment a pharmacologically effective amount of a 1-methylcarbapenem derivative of formula (I-3) in crystalline form as claimed in claim 5.
